Literature DB >> 27260003

Is delayed ischemic preconditioning as effective on running performance during a 5km time trial as acute IPC?

Joost P H Seeger1, Silvie Timmers2, Danique J M Ploegmakers2, N Timothy Cable3, Maria T E Hopman2, Dick H J Thijssen4.   

Abstract

Ischemic preconditioning (IPC) may enhance exercise performance. Cardioprotective effects of IPC are known to re-occur 24h after the stimulus. Whether the delayed effect of IPC has similar effects as IPC on exercise performance is unknown.
OBJECTIVES: Examine whether IPC applied 24h (24-IPC) before exercise is equally effective as IPC in improving exercise performance.
DESIGN: Randomized, cross-over study
METHODS: 12 healthy participants were randomly exposed to SHAM-session, IPC or 24-IPC before a self-paced 5km running trial on a treadmill. Subjects were blinded for time, speed and heart rate. Furthermore, heart rate, BORG, and the local tissue saturation index were measured during exercise, while lactate levels were determined after running. Using a regression model, we explored whether these parameters predicted the change in running time after IPC and 24-IPC.
RESULTS: We found no differences in finish time after IPC (SHAM: 1400±105s, IPC: 1381±112s, 24-IPC: 1385±113s; p=0.30). However, we observed a significant positive relation between the change in finish time after IPC and 24-IPC (p=0.016; r=0.677). Using stepwise linear regression, a lower post-exercise blood lactate level after IPC or 24-IPC was significantly related to an improvement in finish time (R2=0.47, β=-0.687, p=0.007).
CONCLUSIONS: Although no significant effect of IPC or 24-IPC on exercise performance was found, individual finish time after IPC and 24-IPC were strongly correlated. Therefore, our data suggest that, at the individual level, the effects of 24-IPC are closely related to the effects of IPC.
Copyright © 2016 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Athletic performance; Exercise performance; Ischaemic preconditioning; Preconditioning; Time trial

Mesh:

Substances:

Year:  2016        PMID: 27260003     DOI: 10.1016/j.jsams.2016.03.010

Source DB:  PubMed          Journal:  J Sci Med Sport        ISSN: 1878-1861            Impact factor:   4.319


  6 in total

1.  Ischemic preconditioning and exercise performance: shedding light through smallest worthwhile change.

Authors:  Moacir Marocolo; Mario A Moura Simim; Anderson Bernardino; Iury Reis Monteiro; Stephen D Patterson; Gustavo R da Mota
Journal:  Eur J Appl Physiol       Date:  2019-08-26       Impact factor: 3.078

2.  No influence of ischemic preconditioning on running economy.

Authors:  Gungeet Kaur; Megan Binger; Claire Evans; Tiffany Trachte; Gary P Van Guilder
Journal:  Eur J Appl Physiol       Date:  2016-12-23       Impact factor: 3.078

3.  Declines in exercise performance are prevented 24 hours after post-exercise ischemic conditioning in amateur cyclists.

Authors:  Rhaí André Arriel; Hiago Leandro Rodrigues de Souza; Gustavo Ribeiro da Mota; Moacir Marocolo
Journal:  PLoS One       Date:  2018-11-09       Impact factor: 3.240

4.  Effects of different ischemic preconditioning occlusion pressures on muscle damage induced by eccentric exercise: a study protocol for a randomized controlled placebo clinical trial.

Authors:  Eduardo Pizzo Junior; Allysiê Priscilla de Souza Cavina; Leonardo Kesrouani Lemos; Taíse Mendes Biral; Carlos Marcelo Pastre; Franciele Marques Vanderlei
Journal:  Trials       Date:  2021-05-05       Impact factor: 2.279

5.  Ischemic preconditioning does not alter muscle sympathetic responses to static handgrip and metaboreflex activation in young healthy men.

Authors:  Anthony V Incognito; Connor J Doherty; Jordan B Lee; Matthew J Burns; Philip J Millar
Journal:  Physiol Rep       Date:  2017-07

6.  Combining Chronic Ischemic Preconditioning and Inspiratory Muscle Warm-Up to Enhance On-Ice Time-Trial Performance in Elite Speed Skaters.

Authors:  Philippe Richard; François Billaut
Journal:  Front Physiol       Date:  2018-07-31       Impact factor: 4.566

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.